Skip to main content
Download PDF

Preoperative vitamin D level is significantly associated with hypocalcemia after total thyroidectomy

BMC Musculoskeletal Disorders volume 23, Article number: 1118 (2022) Cite this article

Abstract

Background

To evaluate the association of preoperative vitamin D levels with postoperative hypocalcaemia after total thyroidectomy.

Methods

The medical records of patients who underwent total thyroidectomy between May 2020 and January 2022 and who had a documented preoperative serum 25-hydroxyvitamin D (25-OHD) concentration were retrospectively reviewed. Vitamin D levels were categorized into four groups: <10 ng/mL (severe vitamin D deficiency), 10–20 ng/mL (vitamin D deficiency), 20–30 ng/mL (vitamin D insufficiency), and > 30 ng/mL (vitamin D sufficiency). Multivariate logistic regression was performed to analyse the association of vitamin D levels with the risk of hypocalcaemia after controlling for potential confounding factors.

Results

A total of 196 patients were included in this study. Of these, 47 (24.0%) had preoperative 25-OHD < 10 ng/mL, 62 (31.6%) had 25-OHD of 10–20 ng/mL, 51 (26.0%) had 25-OHD of 20–30 ng/mL and the remaining 36 (18.4%) had 25-OHD > 30 ng/mL. The incidence of postoperative hypocalcemia was highest in the group of patients with severe vitamin D deficiency (42.6% and 23.4% for postoperative laboratory and symptomatic hypocalcaemia, respectively), followed by the group with vitamin D deficiency (29.0% and 16.1%), the group with vitamin D insufficiency (19.6% and 5.9%) and the group with vitamin D sufficiency (5.6% and 2.8%). Multivariate logistic regression indicated that the odds of postoperative laboratory hypocalcaemia for patients with severe vitamin D deficiency and vitamin D deficiency were 13.20 times (95% CI: 2.69–64.79, P < 0.01) and 6.32 times (95% CI: 1.32–30.28, P = 0.02) greater than for those with vitamin D sufficiency, respectively; while the odds of symptomatic hypocalcaemia for patients with severe vitamin D deficiency was 10.18 times (95% CI: 1.14–90.86, P = 0.04) greater than for those with vitamin D sufficiency.

Conclusion

Preoperative vitamin D deficiency (< 20 ng/mL), especially severe vitamin D deficiency (< 10 ng/mL), is an independent predictive factor of postoperative hypocalcaemia after total thyroidectomy.

Peer Review reports

Background

Total thyroidectomy is the recommended procedure for a large proportion of thyroid malignancies and benign thyroid pathologies such as Graves’ disease and multinodular goiter. Postoperative hypocalcaemia is the most common complication. As shown in a retrospective cross-sectional study, approximately 19.1% of 126,766 patients who underwent total thyroidectomy developed postoperative hypocalcaemia within 30 days of surgery [1]. Hypocalcaemiacan be asymptomatic, but the condition is sometimes severe and can lead to acute life-threatening conditions, such as tetany, laryngospasm, confusion, seizures, arrhythmias, and heart failure [2]. Although most patients with hypocalcaemia recover within a few months, up to 13% may be permanently affected [3].

Despite an increasing number of studies investigating predictors of postoperative hypocalcaemia, there have been conflicting results regarding the impact of preoperative vitamin D deficiency. A meta-analysis of risk factors for hypocalcaemia after total thyroidectomy pooling the results of eight studies indicated that the incidence of hypocalcaemia was significantly increased in patients with vitamin D deficiency [4]. In contrast, several recently published studies concluded that preoperative vitamin D levels could not predict the risk of postoperative hypocalcaemia [5,6,7]. Some of the reasons for these discordant results could be differences in the criteria used to diagnose hypocalcaemia, diverse cut points for 25-OHD, and study group heterogeneity.

The present study aims to evaluate the potential for using preoperative serum vitamin D concentrations to predict postoperative hypocalcaemia after total thyroidectomy in a homogenous group of patients.

Methods

Patients

This study comprised a retrospective review of all thyroidectomy operations performed at our hospital between May 2020 and January 2022. The inclusion criteria were the performance of total thyroidectomy on adult patients (≥ 18 years) and a documented 25-OHD concentration obtained within one week of the date of surgery. Exclusion criteria were preoperative hypercalcaemia, previous thyroid surgery or irradiation, coexisting parathyroid disease, usage of a drug that interfered with calcium homeostasis, and renal insufficiency.

Data collection and outcomes

Preoperative variables including patient demographics, and preoperative laboratory measurements for 25-OHD, serum calcium, phosphate, parathyroid hormone (PTH), and albumin concentrations were measured within one week before surgery in all patients. Postoperative calcium levels were generally measured at 6 AM and 5 PM on the first postoperative day and 6 AM on the second postoperative day. PTH was measured at the same time as the first calcium measurement on postoperative Day 1.

Patients included in the analysis were divided into four groups according to vitamin D levels: severe deficiency (25-OHD < 10 ng/mL), deficiency (25-OHD of 10–20 ng/mL), insufficiency (25-OHD of 20–30 ng/mL) or sufficiency (25-OHD > 30 ng/mL).

The primary outcomes evaluated were the occurrence of postoperative laboratory hypocalcaemia and symptomatic hypocalcaemia. Laboratory hypocalcaemia was defined as the occurrence of any single adjusted serum calcium concentration less than 8 mg/dl. Serum calcium concentration was adjusted for serum albumin: adjusted calcium = 0.8*(4.0-serum albumin) + serum calcium. Symptomatic hypocalcaemia was defined as subjective or objective symptoms such as tingling, numbness, or carpopedal spasm with laboratory hypocalcaemia. When symptomatic hypocalcaemia developed during a hospital stay, calcium and vitamin D were administered orally. If the symptoms persisted, calcium gluconate was administered intravenously.

Statistical analysis

Continuous variables with normal distribution are presented as means ± SD and compared with the use of One-way Analysis of Variance (ANOVA), followed by post-hoc analysis. All categorical variables were summarised and expressed as proportions and compared with the use of the chi-square test with normal approximation or Fisher’s exact test, as appropriate. Multivariate logistic regression was performed to analyse the association of vitamin D levels with the odds of hypocalcaemia after controlling for potential confounding factors. All tests were 2-sided and a P value of less than 0.05 was considered significant.

All statistical analyses were performed with the SPSS statistical software program package (SPSS version 20.0 for Windows, Armonk, NY: IBM Corp.).

Results

A total of 196 patients were included in this study. Of these, 47 (24.0%) had preoperative severe vitamin D deficiency, 62 (31.6%) had vitamin D deficiency, 51 (26.0%) had vitamin D insufficiency and the remaining 36 (18.4%) had vitamin D sufficiency. The baseline demographics and clinical profiles for the four groups are presented in Table 1. Differences in age, sex, BMI, residence, season of surgery, and preoperative serum calcium, albumin, and PTH were not statistically significant among the four groups (all P > 0.05).

Table 1 Patients’ baseline demographics and clinical characteristics
Full size table

Postoperatively, 50 (25.5%) patients developed hypocalcaemia, and 25 (12.8%) had symptoms of hypocalcaemia. As shown in Fig. 1, the incidence of postoperative hypocalcemia was highest in the group of patients with severe vitamin D deficiency (42.6% and 23.4% for postoperative laboratory and symptomatic hypocalcaemia, respectively), followed by the group with vitamin D deficiency (29.0% and 16.1%), the group with vitamin D insufficiency (19.6% and 5.9%) and the group with vitamin D sufficiency (5.6% and 2.8%).

Fig. 1
figure 1

Incidences of postoperative laboratory and symptomatic hypocalcemia according to preoperative 25-OHD levels. * P < 0.05 compared with 25-OHD 10–20 ng/mL; # P < 0.05 compared with 25-OHD 20–30 ng/mL; ※ P < 0.05 compared with 25-OHD > 30 ng/mL

Full size image

Mean postoperative PTH levels are reported in Fig. 2 according to the four categories of preoperative serum 25-OHD levels. Postoperative PTH levels in patients with severe vitamin D deficiency (16.5 ± 2.9 pg/mL) were significantly lower than those in patients with vitamin D deficiency (31.2 ± 4.7 pg/mL), vitamin D insufficiency (36.7 ± 4.5 pg/mL) and vitamin D sufficiency (36.9 ± 4.1 pg/mL).

Fig. 2
figure 2

Postoperative parathyroid hormone (PTH) levels according to preoperative 25-OHD levels. * P < 0.05 compared with 25-OHD 10–20 ng/mL; # P < 0.05 compared with 25-OHD 20–30 ng/mL; ※ P < 0.05 compared with 25-OHD > 30 ng/mL

Full size image

Multivariate logistic regression (Table 2) revealed that after controlling for potential confounding factors including age, sex, BMI, residence, and preoperative serum calcium, albumin, and PTH, the odds of postoperative laboratory hypocalcaemia for patients with severe vitamin D deficiency and vitamin D deficiency were 13.20 times (95% CI: 2.69–64.79, P < 0.01) and 6.32 times (95% CI: 1.32–30.28, P = 0.02) greater than for those with vitamin D sufficiency, respectively; while the odds of symptomatic hypocalcaemia for patients with severe vitamin D deficiency was 10.18 times (95% CI: 1.14–90.86, P = 0.04) greater than for those with vitamin D sufficiency.

Table 2 Multivariate logistic regression analysis to assess the risk of postoperative laboratory and symptomatic hypocalcemia
Full size table

Discussion

Hypocalcaemia is a well-known postoperative complication of thyroidectomy. Consistent with the incidence of hypocalcaemia ranging from 19 to 38% reported by a meta-analysis and several recent publications [1, 8, 9], laboratory hypocalcaemia was found in 23.8% of patients in this retrospective study. Although hypocalcaemia is often asymptomatic, some clinical symptoms including tingling, numbness, or carpopedal spasm can also be seen, which can limit the routine daily activities of such patients. Symptomatic hypocalcemia was found in 12.8% of patients, which is also consistent with previous studies [9]. In addition, the present study showed that preoperative vitamin D deficiency, especially severe vitamin D deficiency, is associated with an increased risk of postoperative hypocalcaemia.

Vitamin D plays a vital role in the regulation of PTH and calcium [10]. It increases serum calcium by directly increasing calcium absorption from the intestine and bone resorption, and regulating the secretion of PTH from the parathyroid glands [11, 12]. Thus, preoperative vitamin D may exert a profound effect on the perioperative kinetics of calcium and PTH postthyroidectomy [13]. When parathyroid function is impaired, sufficient vitamin D can promote the absorption of intestinal calcium and maintain calcium homeostasis. However, preoperative vitamin D deficiency damaged the regulatory mechanism in patients undergoing total thyroidectomy [14, 15], which increased the incidence of postoperative hypocalcaemia and led to hypoparathyroidism due to parathyroid ischaemia/injury or inadvertent resection. Several studies [16, 17] reported that as the vitamin D level decreased, the calcium level decreased statistically significantly while PTH increased. However, significant associations were not found in the current study. This may be due to the limited sample size in our study as we did not aim to explore the association of preoperative vitamin D levels with calcium and PTH levels.

In previous studies, many different cutoff levels for vitamin D have been explored to predict the risk of postoperative hypocalcaemia. We used three widely accepted cutoff levels of 10, 20, and 30 ng/mL and found that the incidence of postoperative hypocalcaemia was significantly higher for patients with 25-OHD < 10 ng/mL than for those with 25-OHD > 30 ng/mL. Our results are consistent with many previous studies. Al-Khatib and colleagues performed multivariate analysis on 213 patients undergoing total and completion thyroidectomy and showed that severe vitamin D deficiency, defined as serum 25-OHD < 10 ng/ml, was an independent predictor of postoperative hypocalcaemia [18]. A prospective study conducted by Kirkby-Bott et al. reported a dose-dependent relationship between vitamin D level and the risk of hypocalcaemia as hypocalcaemia in patients with vitamin D levels < 10 ng/ml was significantly more likely than hypocalcaemia in patients with vitamin D levels > 20 ng/ml (32% vs. 13%, P < 0.025) [14]. Another prospective study conducted by Daglar et al. indicated that the patients who had < 10 ng/mL vitamin D levels (severe deficiency) developed significantly more biochemical and clinical hypocalcemia than the patients with serum vitamin D levels higher than 10 ng/mL (P = 0.030 and P < 0.001, respectively) [9]. However, some studies have reported diverse results. Two studies conducted by Griffin et al. [8] and Lang et al [12] found no correlation between vitamin D levels and the risk of postoperative hypocalcaemia using vitamin D cutoffs of both 10 and 20 ng/mL [8]. The reasons for these conflicting results could be related to differences in the populations as well as patients’ individual characteristics.

As patients with hypocalcaemia may require longer hospitalization, more biochemical studies, extended pharmacological treatments, and additional medical resources, hypocalcaemia has become a burden for the health care system. Thus, some authors have recommended routine supplementation with calcium or vitamin D. A systematic review indicated that 7 out of the 9 trials included reported statistically significantly reduced rates of postoperative laboratory hypocalcaemia (absolute risk reduction, 13–59%) and symptomatic hypocalcaemia (absolute reduction, 11–40%) following preoperative supplementation [19]. In several guidelines, for patients with a laboratory confirmed vitamin D deficiency (i.e., 25-OHD < 20 ng/ml), an age- and body weight- dependent therapeutic dosage was recommended to be used for 1–3 months; the dosage should be as follows (with ranges dependent on body weight): for neonates 1,000 IU/day; for infants 2,000–3,000 IU/day; for children and adolescents aged 1–18 years 3,000–5,000 IU/day; for adults and the elderly 7,000–10,000 IU/day or 50,000 IU/week [20]. Previous studies have shown that treatment with vitamin D3 (cholecalciferol) takes three to five days to raise serum 25-OHD [21, 22]. In contrast, a single oral dose of calcifediol can generate the needed 25-OHD concentration within four hours [22, 23]. Considering that both D3 and 25-OHD enter immune cells to generate calcitriol, using the combination of D3 (medium-term) and calcifediol (immediate) is cost-effective and leads to the best clinical outcome [22].

Limitations of this study include its retrospective design and findings. Some preoperative and postoperative parameters might be missing, such as data on hypocalcaemia symptoms. In addition, the risk of permanent hypocalcaemia cannot be evaluated due to the lack of long-term follow-up of serum calcaemic levels.

In conclusion, preoperative vitamin D deficiency (25-OHD < 20 ng/mL), especially severe vitamin D deficiency (25-OHD < 10 ng/mL), is an independent predictive factor of postoperative hypocalcaemia after total thyroidectomy. Routine supplementation of vitamin D using the combination of D3 (medium-term) and calcifediol (immediate) with an age- and body weight- dependent therapeutic dosage is recommended for patients with vitamin D deficiency, especially severe vitamin D deficiency, thereby reducing postoperative hypocalcaemia.

Availability of data and materials

The datasets used and/or analyzedanalyzed during the current study are available from the corresponding author upon reasonable request.

References

  1. Liu RH, Razavi CR, Chang HY, Tufano RP, Eisele DW, Gourin CG, Russell JO. Association of Hypocalcemia and Magnesium Disorders with Thyroidectomy in commercially insured patients. JAMA Otolaryngol Head Neck Surg. 2020;146(3):237–46.

    Article  Google Scholar 

  2. Shoback D. Clinical practice. Hypoparathyroidism. N Engl J Med. 2008;359(4):391–403.

    Article  CAS  Google Scholar 

  3. Carvalho GB, Giraldo LR, Lira RB, Macambira IBM, Tapia MA, Kohler HF, Novoa JA, Kowalski LP. Preoperative vitamin D deficiency is a risk factor for postoperative hypocalcemia in patients undergoing total thyroidectomy: retrospective cohort study. Sao Paulo Med J. 2019;137(3):241–7.

    Article  Google Scholar 

  4. Qin Y, Sun W, Wang Z, Dong W, He L, Zhang T, Zhang H. A Meta-analysis of risk factors for transient and permanent Hypocalcemia after total thyroidectomy. Front Oncol. 2020;10:614089.

    Article  Google Scholar 

  5. Manzini G, Malhofer F, Weber T. Can preoperative vitamin D deficiency predict postoperative hypoparathyroidism following thyroid surgery? Langenbecks Arch Surg. 2019;404(1):55–61.

    Article  Google Scholar 

  6. Singh G, Irshaidat F, Lau C, Pedoeem A, Feng C, Fariduddin MM, Min LL, Bansal N. Advancing the understanding of vitamin D status in Post-Thyroidectomy Hypocalcemia. Int J Endocrinol. 2021;2021:5598319.

    Article  Google Scholar 

  7. Soares CSP, Tagliarini JV, Mazeto G. Preoperative vitamin D level as a post-total thyroidectomy hypocalcemia predictor: a prospective study. Braz J Otorhinolaryngol. 2021;87(1):85–9.

    Article  Google Scholar 

  8. Griffin TP, Murphy MS, Sheahan P. Vitamin D and risk of postoperative hypocalcemia after total thyroidectomy. JAMA Otolaryngol Head Neck Surg. 2014;140(4):346–51.

    Article  Google Scholar 

  9. Daglar G, Kilic MO, Celik C, Yuksel C, Terzioglu SG, Ozden S, Icen D. Is there a relationship between vitamin D status and hypocalcemia after total thyroidectomy? Acta Endocrinol (Buchar). 2016;12(3):291–6.

    Article  CAS  Google Scholar 

  10. Cashman KD. Calcium and vitamin D. Novartis Found Symp. 2007;282:123–38. discussion 138–142, 212 – 128.

    Article  CAS  Google Scholar 

  11. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–81.

    Article  CAS  Google Scholar 

  12. Lang BH, Lo CY. Vitamin D3 deficiency is associated with late-onset hypocalcemia after minimally invasive parathyroidectomy in a vitamin D borderline area. World J Surg. 2010;34(6):1350–5.

    Article  Google Scholar 

  13. Forrest KY, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. 2011;31(1):48–54.

    Article  CAS  Google Scholar 

  14. Kirkby-Bott J, Markogiannakis H, Skandarajah A, Cowan M, Fleming B, Palazzo F. Preoperative vitamin D deficiency predicts postoperative hypocalcemia after total thyroidectomy. World J Surg. 2011;35(2):324–30.

    Article  Google Scholar 

  15. Tripathi M, Karwasra RK, Parshad S. Effect of preoperative vitamin D deficiency on postoperative hypocalcemia after thyroid surgery. Thyroid Res. 2014;7:8.

    Article  Google Scholar 

  16. Perez-Castillo IM, Rivero-Blanco T, Leon-Rios XA, Exposito-Ruiz M, Lopez-Criado MS, Aguilar-Cordero MJ. Associations of vitamin D Deficiency, parathyroid hormone, calcium, and Phosphorus with Perinatal adverse outcomes. A prospective cohort study. Nutrients 2020, 12(11).

  17. Valcour A, Blocki F, Hawkins DM, Rao SD. Effects of age and serum 25-OH-vitamin D on serum parathyroid hormone levels. J Clin Endocrinol Metab. 2012;97(11):3989–95.

    Article  CAS  Google Scholar 

  18. Al-Khatib T, Althubaiti AM, Althubaiti A, Mosli HH, Alwasiah RO, Badawood LM. Severe vitamin D deficiency: a significant predictor of early hypocalcemia after total thyroidectomy. Otolaryngol Head Neck Surg. 2015;152(3):424–31.

    Article  Google Scholar 

  19. Khatiwada AS, Harris AS. Use of pre-operative calcium and vitamin D supplementation to prevent post-operative hypocalcaemia in patients undergoing thyroidectomy: a systematic review. J Laryngol Otol. 2021;135(7):568–73.

    Article  CAS  Google Scholar 

  20. Pludowski P, Holick MF, Grant WB, Konstantynowicz J, Mascarenhas MR, Haq A, Povoroznyuk V, Balatska N, Barbosa AP, Karonova T, et al. Vitamin D supplementation guidelines. J Steroid Biochem Mol Biol. 2018;175:125–35.

    Article  CAS  Google Scholar 

  21. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003;77(1):204–10.

    Article  CAS  Google Scholar 

  22. Wimalawansa SJ. Rapidly increasing serum 25(OH)D boosts the Immune System, against infections-Sepsis and COVID-19. Nutrients 2022, 14(14).

  23. Quesada-Gomez JM, Lopez-Miranda J, Entrenas-Castillo M, Casado-Diaz A, Nogues YSX, Mansur JL, Bouillon R. Vitamin D endocrine system and COVID-19: treatment with calcifediol. Nutrients 2022, 14(13).

Download references

Acknowledgements

Not applicable.

Funding

This work is supported by the S&T Program of Chengde (202109A052).

Author information

Authors and Affiliations

  1. Department of Thyroid Surgery, The Affiliated Hospital of Chengde Medical University, No.36, Nanyingzi Street, 067000, Chengde, Hebei Province, China

    Yantao Qi, Jixin Chai, Liuyang Zhang & Yong Chen

Authors
  1. Yantao Qi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jixin Chai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Liuyang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yong Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

YQ and YC conceived the idea and designed the study; JC and LZ collected the data; YQ performed the data analysis and drafted the manuscript; All authors reviewed the manuscript and agreed to submit it.

Corresponding author

Correspondence to Yong Chen.

Ethics declarations

Ethics approval and consent to participate

This study has been reviewed and approved by the Ethical Committee of The Affiliated Hospital of Chengde Medical University. All procedures involving human participants were performed in accordance with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Because this was a retrospective study, informed consent was not required by the Ethical Committee of The Affiliated Hospital of Chengde Medical University.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qi, Y., Chai, J., Zhang, L. et al. Preoperative vitamin D level is significantly associated with hypocalcemia after total thyroidectomy. BMC Musculoskelet Disord 23, 1118 (2022). https://doi.org/10.1186/s12891-022-05977-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12891-022-05977-4

Keywords

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us